OGT-mediated O-GlcNAcylation of BICD2 drives gemcitabine resistance in pancreatic cancer via accelerating G2/M cell cycle progression

Name: OGT-mediated O-GlcNAcylation of BICD2 drives gemcitabine resistance in pancreatic cancer via accelerating G2/M cell cycle progression
Creator: University of Science and Technology of China
Published: 2026-06-26T20:19:27+08:00

integrated proteome resources2026-07-03 收录

胰腺癌耐药机制

G2/M细胞周期调控

数据链接：

https://www.iprox.cn/page/project.html?id=IPX0017957000 数据链接链接失效反馈

官方服务：

资源简介：

OGT-mediated O-GlcNAcylation of BICD2 drives gemcitabine resistance in pancreatic cancer via accelerating G2/M cell cycle progression

提供机构：

University of Science and Technology of China

创建时间：

2026-06-26

OGT-mediated O-GlcNAcylation of BICD2 drives gemcitabine resistance in pancreatic cancer via accelerating G2/M cell cycle progression

资源简介：

相关数据集